Devic's neuromyelitis optica is a syndrome characterised by acute or subacute optic neuritis and transverse myelitis.' In most patients there is no known specific aetiology. Devic's neuromyelitis optica is considered by some,23 but not others,4 to be a variant of multiple sclerosis. The reasons for the particular susceptibility of the optic nerves and spinal cord in these patients is not known. Leber hereditary optic neuropathy (LHON) is the commonest cause of isolated blindness in otherwise healthy young men, and is characterised by a subacute sequential painless visual loss clinically similar to that seen in Devic's syndrome.5 In most cases LHON is a familial condition displaying strict maternal inheritance, although sporadic cases also occur. Over 90% of all patients with LHON harbour one of three point mutations of mitochondrial DNA (mtDNA): these "primary" mutations, at positions 3460 bp, 11 778 bp, and 14 484 bp, have only been documented in families with LHON and not in control populations, and involve moderate or highly conserved amino acids in evolutionarily constrained polpypeptide domains.6 LHON has also been reported in association with a multiple sclerosis-like illness7 8 especially in women. A further report showed the occurrence of LHON mtDNA mutations in a few patients with multiple sclerosis with no family history of LHON, but in whom optic neuritis was a prominent early symptom.9 Despite the prominence of optic nerve symptoms, studies of mtDNA in Devic's syndrome have not been reported.
We have looked for the three primary mtDNA mutations associated with LHON in four unrelated patients with a clinical diagnosis of Devic's syndrome. We also looked for a mutation at 4160 bp which has been seen in families with LHON in association with more widespread neurological disease.'0 All the patients with Devic's syndrome had an acute myelitis followed by unilateral or bilateral optic neuritis within six months. There was no evidence of maternally inherited disease in the families of any of the patients. Brain MRI and routine blood tests were normal in all cases. The table gives clinical details and the results of preliminary investigations.
Methods
Analysis of mtDNA was carried out on cell lysates prepared from whole blood samples from each patient as follows: one plate of washed harvested cells was washed three times in 600 u1 buffer containing 10 mM Tris Cl (pH 8 0) and 1 mM EDTA, with pelleting by centrifugation at 15 000 g for five minutes. The presence or absence of the mtDNA 
